Page last updated: 2024-08-17

tetrabenazine and Chorea

tetrabenazine has been researched along with Chorea in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-199015 (26.32)18.7374
1990's2 (3.51)18.2507
2000's8 (14.04)29.6817
2010's19 (33.33)24.3611
2020's13 (22.81)2.80

Authors

AuthorsStudies
Bachoud-Levi, AC; Bentivoglio, AR; Burgunder, JM; Cardoso, F; Claassen, DO; Costa, J; Duarte, GS; Ferreira, JJ; Furr-Stimming, E; Kulisevsky, J; Landwehrmeyer, GB; Mestre, TA; Nirenberg, MJ; Rodrigues, FB; Rosser, A; Roth, J; Sampaio, C; Seppi, K; Slawek, J; Tabrizi, SJ; Vandenberghe, W; Walker, FO1
Bharate, SS; Devadiga, SJ1
Edmondson, MC; Frank, S; Goldstein, J; Gordon, MF; Gross, N; Kayson, E; Leavitt, BR; O'Neill, C; Oakes, D; Savola, JM; Testa, C; Vaughan, C; Whaley, J1
Calopa, M; Ferré, A; Gamez, J; Huertas, O; Insa, R; Kulisevsky, J; McAllister, K; Muñoz, E; Reig, N; Scart-Grès, C1
Heim, B; Seppi, K1
Claassen, DO; Furr Stimming, E; Goldstein, J; Haubenberger, D; Kayson, E; Liang, GS; Mehanna, R; Zhang, H1
Bachoud-Lévi, AC; Blasco-Amaro, JA; Capuano, A; Isabel-Gómez, R; Martín-Gómez, C; Nou-Fontanet, L; Ortigoza-Escobar, JD; Zorzi, G1
Ceccarelli, L; Gigli, GL; Merlino, G; Sperotto, R; Tereshko, Y; Valente, M1
Carroll, B; Claassen, DO; Philbin, M1
Akbostanci, MC; Sahin, T; Yilmaz, R1
Alboudi, A; Sanders, AK; Schichtel, LT; Tolla, AS1
Dashtipour, K; Koch, J; Shi, WX1
Ciacciarelli, A; Currò, CT; Girlanda, P; Nicocia, G; Russo, G; Terranova, C; Toscano, A; Ziccone, V1
Claassen, DO; Gibson, JS1
Claassen, DO; Colcher, A; Davis, C; Duker, A; Eberly, S; Elmer, L; Frank, S; Furr-Stimming, E; Goldstein, J; Gudesblatt, M; Hunter, C; Jankovic, J; Kayson, E; Kostyk, SK; Kumar, R; Loy, C; Mallonee, W; Oakes, D; Scott, BL; Stamler, D; Sung, V; Testa, CM; Vaughan, C1
Heo, YA; Scott, LJ1
Bashir, H; Jankovic, J1
DeWitt, SH; Maryanoff, BE1
Abler, V; Claassen, DO; DiBonaventura, M; Gandhi, SK; Iyer, RG; Shah-Manek, B; Sung, VW1
Ferreira, JJ; Rodrigues, FB; Wild, EJ1
Bednarczyk, EM; Russak, EM1
Altavilla, R; Arosio, C; di Biase, L; Frontali, M; Marano, M; Melgari, JM; Nuovo, S; Piperno, A; Quattrocchi, CC; Salomone, G; Scrascia, F; Siotto, M; Squitti, R; Vernieri, F1
Geschwind, MD; Paras, N1
Agarwal, P; Anderson, KE; Beck, C; Beland, M; Blindauer, KA; Boyd, JT; Brashers-Krug, T; Carlson, A; Chouinard, S; Christopher, E; Claassen, DO; Clouse, R; Colcher, A; Criswell, S; Davis, C; Dhall, R; Dubinsky, RM; Duker, A; Eberly, SW; Edicola, J; Edmondson, MC; Eglow, M; Esmail, S; Evans, S; Factor, SA; Fafard, L; Farbman, ES; Feigin, A; Frank, S; Fung, WL; Gibbons, C; Goldstein, J; Graffitti, L; Gray, C; Gudesblatt, M; Hackmyer, C; Heller, H; Herzog, M; Hickey, PT; Hohler, A; Houston, E; Hunter, C; James, RC; Janicki, S; Jankovic, J; Jimenez-Shahed, J; Kayson, E; Kerr, J; Kinel, S; Klos, K; Kumar, R; LaFaver, K; Leavitt, B; Margolis, RL; McGarry, A; Mendis, N; Mendis, T; Miller, A; Molho, E; Neefus, E; Nucifora, F; O'Neill, C; Oakes, D; Ong, M; Orme, C; Paulsen, JS; Qi, L; Quesada, M; Racette, BA; Reeves, C; Revilla, FJ; Rizer, K; Rodriguez, R; Roman, OC; Saint-Hilaire, M; Samii, A; Schneider, DP; Scott, BL; Shprecher, D; Singer, C; Smith, J; Snively, V; Sperin, E; Stamler, D; Sung, V; Suter, G; Tariot, PN; Testa, CM; Turpin, D; Vaughan, C; Wall, P; Watts, A; Whaley, J; Wheeler, L; Wilson-Perez, H; Wojcieszek, JM; Wong, C1
Hayden, MR; Kirkpatrick, P; Leavitt, BR; Yasothan, U1
Clark, J; Dobbins, EK; DuVall, CA; Neumiller, JJ; Santiago, A; Setter, SM; Wood, L1
Bernardi, G; Bernardini, S; Fusco, FR; Giampà, C; Laurenti, D; Morello, M; Nuccetelli, M; Ottaviani, F; Paolucci, S; Pompa, A; Sabatini, U1
Andrich, J; Reber, D; Saft, C; Streuer, M1
Clarence-Smith, K; Jankovic, J1
Bramanti, P; Calabrò, RS; Gervasi, G; Polimeni, G1
Scott, LJ1
Cavanna, AE1
Chen, JJ; Dashtipour, K; Ondo, WG; Swope, DM1
Billette de Villemeur, T; Camuzat, A; Caubel, I; Chantot-Bastaraud, S; Charles, P; Devos, D; Doummar, D; Durr, A; Epaud, R; Goizet, C; Gras, D; Guillot, L; Héron, B; Jonard, L; Kemlin, I; Koht, J; Lion-François, L; Louha, M; Motte, J; Moutard, ML; Polak, M; Rodriguez, D; Roze, E; Sanlaville, D; Tallot, M; Vidailhet, M; Vuillaume, I1
Chatterjee, A; Frucht, SJ1
SATTES, H1
MOLLER-CHRISTENSEN, B; VIDEBECH, T1
Ondo, WG; Sitburana, O1
Davidson, A; Hunter, C; Jankovic, J; Kenney, C1
Bonelli, RM; Hofmann, P1
Login, IS; Savani, AA1
Lang, AE; Marsden, CD1
Lubbe, WF; Walker, EB1
Jankovic, J1
Linazasoro, G; Martí Massó, JF; Poza, JJ; Suárez, JA; Urtasun, M1
Albin, RL; Bohnen, NI; Fink, JK; Frey, KA1
Bohan, A; Hutchinson, M; O' Donoghue, D; Owens, A; Shanahan, P; Sheahan, K1
Fortemps, E; Laterre, EC1
Nyberg-Hansen, R1
Godwin-Austen, RB1
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM1
Hawkes, CH; Nourse, CH1
Jankovic, J; Orman, J1
Dalby, MA1
Gilligan, BS; Munro, OR; Veale, JL; Wodak, J1
Marsden, CD1
Gordon, N1

Reviews

14 review(s) available for tetrabenazine and Chorea

ArticleYear
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
    Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:1

    Topics: Apathy; Chorea; Humans; Huntington Disease; Movement Disorders; Tetrabenazine

2022
Recent developments in the management of Huntington's disease.
    Bioorganic chemistry, 2022, Volume: 120

    Topics: Anxiety; Chorea; Humans; Huntington Disease; Tetrabenazine

2022
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.
    European journal of neurology, 2023, Volume: 30, Issue:12

    Topics: Carbidopa; Chorea; Clonazepam; Humans; Levodopa; Methylphenidate; Tetrabenazine

2023
The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review.
    Medicina (Kaunas, Lithuania), 2023, Nov-04, Volume: 59, Issue:11

    Topics: Aged, 80 and over; Chorea; COVID-19; Diabetes Mellitus; Female; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; SARS-CoV-2; Tetrabenazine

2023
Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:18

    Topics: Chorea; Dopamine Antagonists; Humans; Huntington Disease; Quality of Life; Tardive Dyskinesia; Tetrabenazine

2019
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.
    Pharmacology & therapeutics, 2020, Volume: 212

    Topics: Animals; Chorea; Clinical Trials as Topic; Dopamine; Humans; Huntington Disease; Hyperkinesis; Synaptic Transmission; Tardive Dyskinesia; Tetrabenazine; Vesicular Monoamine Transport Proteins

2020
Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Drugs, 2017, Volume: 77, Issue:17

    Topics: Administration, Oral; Chorea; Drug Interactions; Humans; Huntington Disease; Tetrabenazine; Vesicular Monoamine Transport Proteins

2017
Treatment options for chorea.
    Expert review of neurotherapeutics, 2018, Volume: 18, Issue:1

    Topics: Antipsychotic Agents; Chorea; Deep Brain Stimulation; Dopamine Antagonists; Humans; Piperidines; Tetrabenazine; Transcranial Magnetic Stimulation; Valine; Vesicular Monoamine Transport Proteins

2018
Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals.
    The Annals of pharmacotherapy, 2019, Volume: 53, Issue:2

    Topics: Chorea; Deuterium; Drug Approval; Humans; Huntington Disease; Legislation, Drug; Pharmaceutical Preparations; Pharmacokinetics; Tardive Dyskinesia; Tetrabenazine; Toxicity Tests; United States; United States Food and Drug Administration

2019
Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2009, Volume: 24, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Chorea; Clinical Trials as Topic; Drug Interactions; Humans; Huntington Disease; Patient Education as Topic; Tetrabenazine

2009
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Expert review of neurotherapeutics, 2011, Volume: 11, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Chorea; Humans; Hyperkinesis; Tetrabenazine

2011
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Clinical therapeutics, 2012, Volume: 34, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Animals; Chorea; Dystonia; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Rare Diseases; Tetrabenazine; Tic Disorders

2012
A systematic review of the treatment studies in Huntington's disease since 1990.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2

    Topics: Amantadine; Antipsychotic Agents; Chorea; Depression; Humans; Huntington Disease; Neuroprotective Agents; Riluzole; Sexual Dysfunctions, Psychological; Tetrabenazine

2007
Hemichorea, moya-moya, and ulcerative colitis.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:3

    Topics: Adolescent; Anti-Dyskinesia Agents; Cerebral Angiography; Chorea; Colitis, Ulcerative; Female; Humans; Magnetic Resonance Imaging; Moyamoya Disease; Tetrabenazine; Treatment Outcome

2001

Trials

9 trial(s) available for tetrabenazine and Chorea

ArticleYear
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
    CNS drugs, 2022, Volume: 36, Issue:11

    Topics: Chorea; Double-Blind Method; Humans; Huntington Disease; Tetrabenazine; Treatment Outcome

2022
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:5

    Topics: Chorea; Double-Blind Method; Humans; Huntington Disease; Tetrabenazine; Treatment Outcome; Vesicular Monoamine Transport Proteins

2023
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
    The Lancet. Neurology, 2023, Volume: 22, Issue:6

    Topics: Adult; Antipsychotic Agents; Chorea; Double-Blind Method; Female; Humans; Huntington Disease; Male; Tetrabenazine; Treatment Outcome

2023
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
    JAMA, 2016, Jul-05, Volume: 316, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Chorea; Cytochrome P-450 CYP2D6; Double-Blind Method; Drug Administration Schedule; Female; Humans; Huntington Disease; Maintenance Chemotherapy; Male; Middle Aged; Tetrabenazine; Treatment Outcome

2016
Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:1

    Topics: Adult; Aged; Anti-Dyskinesia Agents; Chorea; Female; Humans; Huntington Disease; Male; Middle Aged; Severity of Illness Index; Tetrabenazine; Time Factors

2007
Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Annals of neurology, 1982, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Athetosis; Blepharospasm; Child; Chorea; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Middle Aged; Neuromuscular Diseases; Tetrabenazine

1982
[Attempt at the quantification of choreic movements by a photographic method].
    La Nouvelle presse medicale, 1976, May-01, Volume: 5, Issue:18

    Topics: Anthropometry; Chorea; Clinical Trials as Topic; Fingers; Haloperidol; Humans; Movement; Neurologic Examination; Phenothiazines; Photography; Tetrabenazine

1976
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Neurology, 1988, Volume: 38, Issue:3

    Topics: Chorea; Clinical Trials as Topic; Drug Synergism; Dystonia; Humans; Lithium; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease, Secondary; Tetrabenazine; Tic Disorders

1988
Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    The Medical journal of Australia, 1972, Nov-04, Volume: 2, Issue:19

    Topics: Adolescent; Adult; Athetosis; Basal Ganglia Diseases; Chorea; Clinical Trials as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Placebos; Spasm; Tetrabenazine

1972

Other Studies

34 other study(ies) available for tetrabenazine and Chorea

ArticleYear
Valbenazine as treatment for Huntington's disease chorea.
    The Lancet. Neurology, 2023, Volume: 22, Issue:6

    Topics: Chorea; Humans; Huntington Disease; Tetrabenazine; Valine

2023
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
    Parkinsonism & related disorders, 2020, Volume: 74

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Chorea; Drug-Related Side Effects and Adverse Reactions; Dystonic Disorders; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Tic Disorders; Turkey; Young Adult

2020
Anterior choroidal artery infarct presenting as right hemichoreoathetosis.
    BMJ case reports, 2020, May-11, Volume: 13, Issue:5

    Topics: Aged, 80 and over; Athetosis; Cerebral Infarction; Chorea; Dopamine Antagonists; Female; Humans; Ischemic Stroke; Risperidone; Tetrabenazine

2020
Pimozide and pancreatic cancer in diabetic chorea: a case report.
    The International journal of neuroscience, 2022, Volume: 132, Issue:12

    Topics: Aged; Blood Glucose; Chorea; Diabetes Mellitus; Dyskinesias; Female; Humans; Pancreatic Neoplasms; Pimozide; Tetrabenazine

2022
State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:8

    Topics: Antipsychotic Agents; Chorea; Humans; Huntington Disease; Prospective Studies; Tetrabenazine

2021
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
    JAMA neurology, 2017, 08-01, Volume: 74, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Australia; Chorea; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Middle Aged; Severity of Illness Index; Tetrabenazine; Treatment Outcome; United States

2017
Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine
    Biochemistry, 2018, 02-06, Volume: 57, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Animals; Biochemistry; Chorea; Deuterium; Drug and Narcotic Control; Drug Approval; Drug Discovery; Humans; Tardive Dyskinesia; Tetrabenazine

2018
Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
    Current medical research and opinion, 2018, Volume: 34, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Chorea; Cross-Sectional Studies; Depression; Female; Humans; Huntington Disease; Male; Middle Aged; Perception; Physicians; Quality of Life; Surveys and Questionnaires; Tetrabenazine; United States

2018
Physician perception versus true efficacy of tetrabenazine for Huntington's disease.
    Current medical research and opinion, 2018, Volume: 34, Issue:9

    Topics: Chorea; Humans; Huntington Disease; Physicians; Tetrabenazine; United States

2018
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Brain; Ceruloplasmin; Chorea; Diagnosis, Differential; Dystonia; Female; Humans; Iron Metabolism Disorders; Iron Overload; Middle Aged; Movement Disorders; Neurodegenerative Diseases; Tetrabenazine; Treatment Outcome

2015
Deutetrabenazine for Treatment of Chorea in Huntington Disease.
    JAMA, 2016, Jul-05, Volume: 316, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Chorea; Female; Humans; Huntington Disease; Male; Tetrabenazine

2016
Tetrabenazine.
    Nature reviews. Drug discovery, 2009, Volume: 8, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Chorea; Clinical Trials as Topic; Drug Approval; Humans; Huntington Disease; Tetrabenazine; United States; United States Food and Drug Administration

2009
A case of PANDAS treated with tetrabenazine and tonsillectomy.
    Journal of child neurology, 2010, Volume: 25, Issue:5

    Topics: Anti-Dyskinesia Agents; Antistreptolysin; Autoantibodies; Autoimmune Diseases of the Nervous System; Brain; Child; Chorea; Combined Modality Therapy; Humans; Male; Mental Disorders; Streptococcal Infections; Syndrome; Tetrabenazine; Tonsillectomy; Treatment Outcome

2010
Post pump chorea in a 77-year-old male.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2011, Volume: 32, Issue:4

    Topics: Aged; Anti-Dyskinesia Agents; Aortic Valve; Cardiopulmonary Bypass; Chorea; Delirium; Dyskinesias; Heart Valve Prosthesis Implantation; Humans; Male; Neurologic Examination; Risk Factors; Surgical Instruments; Tetrabenazine

2011
Postthalamic stroke dystonic choreoathetosis responsive to tetrabenazine.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:12

    Topics: Antipsychotic Agents; Athetosis; Chorea; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Middle Aged; Stroke; Tetrabenazine

2011
Tetrabenazine: for chorea associated with Huntington's disease.
    CNS drugs, 2011, Dec-01, Volume: 25, Issue:12

    Topics: Animals; Chorea; Clinical Trials as Topic; Dopamine; Double-Blind Method; Drug Evaluation, Preclinical; Humans; Huntington Disease; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tetrabenazine; Vesicular Monoamine Transport Proteins

2011
Behavioural and cognitive dysfunction across basal ganglia disorders.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Chorea; Chromosome Disorders; Female; Humans; Male; Mutation; Nuclear Proteins; Tetrabenazine; Thyroid Nuclear Factor 1; Transcription Factors

2012
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Chorea; Chromosome Disorders; Cognition Disorders; Congenital Hypothyroidism; DNA Mutational Analysis; Female; Follow-Up Studies; France; Genes, Dominant; Humans; Infant; Male; Mutation; Neuropsychological Tests; Nuclear Proteins; Phenotype; Prognosis; Protein Array Analysis; Respiratory Tract Diseases; Tetrabenazine; Thyroid Nuclear Factor 1; Transcription Factors; Treatment Outcome

2012
Tetrabenazine in the treatment of severe pediatric chorea.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:6

    Topics: Anti-Dyskinesia Agents; Cerebral Palsy; Child; Child, Preschool; Chorea; Down Syndrome; Encephalitis; Humans; Infant; Male; Spasms, Infantile; Tetrabenazine; Treatment Outcome

2003
[The treatment of chorea minor with the monoamine liberator "Nitoman"].
    Psychiatria et neurologia, 1960, Volume: 140

    Topics: Amines; Chorea; Humans; Tetrabenazine; Tranquilizing Agents

1960
[Treatment of Huntington's chorea with tetrabenazine (Nitoman)].
    Ugeskrift for laeger, 1963, Feb-08, Volume: 125

    Topics: Chorea; Humans; Huntington Disease; Tetrabenazine

1963
Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11

    Topics: Aged; Anti-Dyskinesia Agents; Chorea; Dyskinesias; Female; Functional Laterality; Humans; Hyperglycemia; Magnetic Resonance Imaging; Tetrabenazine

2006
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Neurology, 2007, Mar-06, Volume: 68, Issue:10

    Topics: Anti-Dyskinesia Agents; Chorea; Humans; Huntington Disease; Randomized Controlled Trials as Topic; Tetrabenazine

2007
Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Clinical neuropharmacology, 1982, Volume: 5, Issue:4

    Topics: Adult; alpha-Methyltyrosine; Chorea; Drug Therapy, Combination; Dystonia; Female; Humans; Male; Methyltyrosines; Middle Aged; Movement Disorders; Tetrabenazine; Tyrosine 3-Monooxygenase

1982
Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report.
    British journal of obstetrics and gynaecology, 1983, Volume: 90, Issue:5

    Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Female; Humans; Infant, Newborn; Lupus Coagulation Inhibitor; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Tetrabenazine

1983
Generalized chorea induced by nonketotic hyperglycemia.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Chorea; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Insulin; Neurologic Examination; Tetrabenazine

1993
(+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis.
    Neurology, 1999, Mar-23, Volume: 52, Issue:5

    Topics: Adult; Aged; Athetosis; Binding Sites; Carbon Radioisotopes; Chorea; Dystonia; Humans; Kinetics; Male; Middle Aged; Tetrabenazine; Tomography, Emission-Computed

1999
[Editorial: Treatment of choriatic movements].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1975, Nov-30, Volume: 95, Issue:33

    Topics: Chorea; Humans; Huntington Disease; Lithium; Tetrabenazine; Tranquilizing Agents

1975
The treatment of the choreas and athetotic dystonias.
    Journal of the Royal College of Physicians of London, 1979, Volume: 13, Issue:1

    Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid

1979
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12

    Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis

1977
Tetrabenazine in Sydenham's chorea.
    British medical journal, 1977, May-28, Volume: 1, Issue:6073

    Topics: Acute Disease; Child; Chorea; Female; Humans; Male; Syndrome; Tetrabenazine

1977
Effect of tetrabenazine on extrapyramidal movement disorders.
    British medical journal, 1969, May-17, Volume: 2, Issue:5654

    Topics: Chorea; Extrapyramidal Tracts; Female; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Tetrabenazine

1969
Drug treatment of diseases characterized by abnormal movements.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:9

    Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor

1973
Drugs and motor functions.
    Developmental medicine and child neurology, 1971, Volume: 13, Issue:3

    Topics: Athetosis; Catecholamines; Cholinesterase Inhibitors; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Histamine H1 Antagonists; Humans; Motor Activity; Movement Disorders; Parkinson Disease; Phenothiazines; Reserpine; Tetrabenazine

1971